Patent · US Active

Compounds and methods for treating cancer

US9011880B2 · kind B2 · utility

0Cited by
6References
37Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 16, 2010
Grant dateApr 21, 2015
Priority date
Expiry dateMay 9, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides a method of treating cancer involving administering an insulin-like growth factor-1 receptor (IGF-1 receptor) agonist and an anti-cancer chemotherapeutic agent. Also provided are compounds for treating cancer comprising an IGF-1-receptor ligand coupled to an anti-cancer chemotherapeutic agent. Also provided are compounds for treating cancer comprising an insulin-receptor ligand coupled to an anti-cancer chemotherapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.